Michael C Deeley

Title: Innovations of Michael C Deeley in Chemokine Research

Introduction

Michael C Deeley is an accomplished inventor based in Edmonds, WA (US). He has made significant contributions to the field of chemokine research, particularly through his innovative work on macrophage-derived chemokines. With a total of 2 patents, Deeley's inventions have the potential to impact therapeutic applications in various medical fields.

Latest Patents

Deeley's latest patents focus on the Macrophage Derived Chemokine (MDC) and its analogs. The first patent provides purified and isolated polynucleotide sequences encoding MDC, along with polypeptide fragments and analogs. It also details methods for the recombinant or synthetic production of the chemokine and its fragments. Additionally, the patent includes antibodies reactive with MDC and assays for identifying modulators of MDC chemokine activity. The second patent further explores MDC and its analogs, providing similar materials and methods for their production and therapeutic uses.

Career Highlights

Michael C Deeley is associated with Icos Corporation, where he has been instrumental in advancing research related to chemokines. His work has contributed to a deeper understanding of the role of chemokines in immune responses and potential therapeutic interventions.

Collaborations

Deeley has collaborated with notable colleagues, including Patrick W Gray and David H Chantry. These collaborations have fostered a productive research environment, leading to significant advancements in their field.

Conclusion

Michael C Deeley's innovative work in chemokine research exemplifies the impact of dedicated inventors in the scientific community. His contributions continue to pave the way for future advancements in therapeutic applications.